# Nuclide record al2846 (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/al2846/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "al2846" ;
  schema:name "AL2846"@en ;
  schema:description "AL2846 is an experimental small-molecule drug from Chia Tai Tianqing Pharmaceutical in phase 3 trials for thyroid cancer, aimed at MET and RET."@en ;
  schema:url <https://nuclide.cc/drugs/al2846/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=AL2846> ;
  nuclide:status "phase-3" ;
  nuclide:tag "pipeline", "ctgov-ingest" ;
  nuclide:modality "small molecule (structure undisclosed or not yet in PubChem)" ;
  nuclide:indications <https://nuclide.cc/indications/thyroid/> ;
  nuclide:trials <https://nuclide.cc/trials/nct06860971/> .